Cargando…
Erythrocyte membrane affinity chromatography, solid-phase extraction and UPLC-QTOF-MS/MS to screen active ingredients of Buyang Huanwu decoction
Buyang Huanwu decoction (BHD) is a well-known traditional Chinese medicine that has long been used to treat ischemic brain damage which is associated with hemorheology. To screen active ingredients in BHD responsible for reducing blood viscosity by reducing red blood cell (RBC) lesions to treat isch...
Autores principales: | Yu, Aiming, Zheng, Huazhu, Yan, Xiangli, Wang, Shengxin, Shen, Xiao, Zheng, Haozhen, Meng, Yingjiao, Wang, Lisheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071827/ https://www.ncbi.nlm.nih.gov/pubmed/35528420 http://dx.doi.org/10.1039/c9ra03447a |
Ejemplares similares
-
Cell Chromatography-Based Screening of the Active Components in Buyang Huanwu Decoction Promoting Axonal Regeneration
por: Yan, Xiangli, et al.
Publicado: (2019) -
Anti-Inflammatory Effects of Modified Buyang Huanwu Decoction
por: Ryu, Hyang-Hwa, et al.
Publicado: (2020) -
Comparative study on brain pharmacokinetics of Buyang Huanwu Decoction in normal and cerebral ischemia rats using brain microdialysis combined with LC-MS/MS
por: Liu, Wanyi, et al.
Publicado: (2022) -
Neuroprotective effects of Buyang Huanwu decoction on cerebral ischemia-induced neuronal damage
por: Mu, Qingchun, et al.
Publicado: (2014) -
Chemical characterization and metabolic profiling of Xiao-Er-An-Shen Decoction by UPLC-QTOF/MS
por: Yang, Ruipei, et al.
Publicado: (2023)